Plain-English translation of NCT07666711 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Nephritis research guide →This study is looking for early warning signs — called biomarkers — in blood and urine that can help doctors detect and monitor kidney disease caused by lupus. Researchers will follow about 500 adults with lupus over 5 years, collecting regular blood and urine samples along with standard clinical information. The goal is to discover which biomarkers best predict kidney problems, so doctors can catch and treat them earlier.
Kidney disease is a serious complication of lupus, but detecting it early is challenging. This research aims to develop better blood and urine tests that can warn doctors about kidney involvement before major damage occurs, potentially preventing serious complications and improving long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would visit your regular medical center multiple times over up to 5 years to provide blood and urine samples for biomarker testing. Your doctor will also collect routine clinical information about your lupus, current treatments, and any kidney-related symptoms or test results. Some participants may undergo a kidney biopsy if biomarker results suggest possible kidney involvement — this would only be done if your doctor believes it is safe and appropriate for you.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Norway